Fact 6: Akathisia and Medication Withdrawal
The narrative of akathisia often revolves around its emergence in conjunction with the introduction of certain medications. However, akathisia can also surface when certain drugs are discontinued, a phenomenon known as withdrawal akathisia. This type of akathisia is typically associated with the cessation of antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), and benzodiazepines.
Withdrawal akathisia typically rears its head within six weeks of stopping the medication. However, this timeline is not set in stone, and akathisia can occur later in some individuals. The onset of restlessness and discomfort following medication discontinuation can be a distressing experience. This discomfort is often accompanied by other withdrawal symptoms like anxiety, dizziness, and disturbed sleep.
Identifying withdrawal akathisia is crucial, primarily because it underscores the importance of correct medication discontinuation practices. Abrupt cessation of certain medications can trigger withdrawal symptoms, including akathisia. Therefore, a gradual tapering of the medication, under the supervision of a healthcare provider, is recommended.
If an individual begins to exhibit signs of akathisia following the discontinuation of a medication, it’s essential to seek medical advice promptly. The healthcare provider can then evaluate the symptoms, consider the possibility of withdrawal akathisia, and recommend appropriate management strategies.
Effective management might include reintroducing the medication and then gradually reducing the dosage, or introducing other interventions to alleviate the symptoms. The key is to manage withdrawal akathisia without compromising the treatment of the individual’s primary condition. (6)
